Scynexis Inc (SCYX): EPS (Basic)
-$0.17
Year ended 2025-12-31
| Period ended | EPS (Basic) | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | -$0.17 | n/m | 2026-03-04, From 2025-01-01 |
| 2024-12-31 | -$0.44 | n/m | 2026-03-04, From 2024-01-01 |
| 2023-12-31 | $1.40 | n/m | 2025-03-12, From 2023-01-01 |
| 2022-12-31 | -$1.47 | n/m | 2024-03-28, From 2022-01-01 |
| 2021-12-31 | -$1.25 | n/c | 2023-03-31, From 2021-01-01 |
| No annual figure between 2016-12-31 and 2021-12-31. | |||
| 2016-12-31 | -$1.58 | n/m | 2017-03-13, From 2016-01-01 |
| 2015-12-31 | -$2.68 | n/m | 2017-03-13, From 2015-01-01 |
| 2014-12-31 | -$1.04 | n/m | 2017-03-13, From 2014-01-01 |
| 2013-12-31 | -$139.47 | n/a | 2015-03-30, From 2013-01-01 |
EPS (Basic) at similar companies
| Company | Year ended | EPS (Basic) | Change YoY |
|---|---|---|---|
| Scynexis Inc (SCYX) | 2025-12-31 | -$0.17 | n/m |
| CASI Pharmaceuticals, Inc. (CASIF) | 2025-12-31 | -$2.59 | n/m |
| Evofem Biosciences, Inc. (EVFM) | 2025-12-31 | $0.00 | n/m |
| Sol-Gel Technologies Ltd. (SLGL) | 2025-12-31 | -$2.19 | n/m |
| NewAmsterdam Pharma Co N.V. (NAMS) | 2025-12-31 | -$1.72 | n/m |
| Alumis Inc. (ALMS) | 2025-12-31 | -$2.86 | n/m |
| Entrada Therapeutics, Inc. (TRDA) | 2025-12-31 | -$3.47 | n/m |
| uniQure N.V. (QURE) | 2025-12-31 | -$3.46 | n/m |
| Celularity Inc (CELU) | 2025-12-31 | -$3.59 | n/m |
Compare SCYX, CASIF, EVFM, SLGL side by side · Screen every company in Pharmaceutical Preparations ↗